Discover 1,407 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,407
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
for
Low Grade Serous Ovarian Cancer
Location: Cleveland OH, Detroit MI, Pittsburgh PA, Hilliard OH,
Sponsor: Verastem, Inc.
Sex: Female
Age: 18+
Code: NCT06072781
Phase 3, Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Location: Cleveland OH, Detroit MI, Pittsburgh PA, Toronto,
Sponsor: Eidos Therapeutics, a BridgeBio company
Sex: All
Age: 18 - 70+
Code: NCT06563895
Phase 3, Recruiting
Functional Brain Network Changes in Patients Undergoing Deep Brain Stimulation for Essential Tremor
for
Essential Tremor
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 30 - 70+
Code: NCT06293638
Recruiting
Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma
for
Mild Autonomous Cortisol Secretion (MACS)
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT06344143
Recruiting
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
for
Primary Open Angle Glaucoma
Location: Cleveland OH, Fraser MI, Cincinnati OH,
Sponsor: AbbVie
Sex: All
Age: 45+
Code: NCT06822738
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
for
Autosomal Recessive Polycystic Kidney (ARPKD)
Location: Cleveland OH, Ann Arbor MI, Cincinnati OH,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 0 - 18
Code: NCT04782258
Phase 3, Recruiting
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass